Bench-to-bedside review: Iron metabolism in critically ill patients

Critical Care

Volumn 8, Issue 5, 2004, Pages 356-362

  Darveau, Martin ^a,b   Denault, André Y ^c   Blais, Normand ^d   Notebaert, Éric ^e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Cite de la Sante de Laval   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d Cite de la Sante de Laval   (Canada)

^e Critical Care Department   (Canada)

Author keywords

Critical illness; Erythropoiesis; Iron metabolism

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

BACTERIAL CELL; BACTERIAL GROWTH; BLOOD TRANSFUSION; CELL PROLIFERATION; CRITICAL ILLNESS; DRUG EFFICACY; DRUG SAFETY; ERYTHROPOIESIS; HEMODIALYSIS; HUMAN; INFECTION SENSITIVITY; INFLAMMATION; INTENSIVE CARE; IRON DEFICIENCY ANEMIA; IRON METABOLISM; KIDNEY FAILURE; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ANEMIA; CRITICAL CARE; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FERRITINS; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS; IRON;

EID: 7944226815     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2862     Document Type: Review

References (31)

1. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D: Anemia and blood transfusion in critically ill patients. JAMA 2002, 288: 499-1507.
2. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot M, Duh MS, Shapiro MJ: The CRIT study: anemia and blood transfusion in the critically III - current clinical practice in the United States. Crit Care Med 2004, 32:39-52.
3. von Ahsen N, Müller C, Serke S, Frei U, Eckardt KU: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999, 27:2630-2639.
4. Ba VN, Bota DP, Mélot C, Vincent J: Time course of hemoglobin concentrations in non bleeding intensive care unit patients. Crit Care Med 2003, 31:406-410.
5. Means RT: Recent developments in the anemia of chronic disease. Curr Hematol Rep 2003, 2:116-121.
6. Means RT: The anemia of chronic disorders. In Wintrobe's Clinical Hematology. Edited by Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM. Baltimore, Maryland: Williams & Wilkins; 1999:1011-1021.
7. Sears DA: Anemia of chronic disease. Med Clin North Am 1992, 76:567-579.
8. Adamson JW: Iron deficiency and other hypoproliferative anemias. In Harrison's Principles of Internal Medicine. Edited by Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. New York: McGraw-Hill; 2001:660-666.
9. Jurado RL: Iron, infections, and anemia of inflammation. Clin Infect Dis 1997, 25:888-895.
10. Hillman RS: Iron deficiency and other hypoproliferative anemias. In Harrison's Principles of Internal Medicine. Edited by Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL. New York: McGraw-Hill; 1998:638-645.
11. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Scheitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirement in critical care. N Engl J Med 1999, 340:409-417.
12. Darveau M, Notebaert E, Denault AY, Bélisle S: Recombinant human erythropoietin use in intensive care. Ann Pharmacother 2002, 36:1068-1074.
13. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T: Efficacy of recombinant human erythropoietin in critically ill patients. JAMA 2002, 288:2827-2835.
14. Ganz T: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102: 83-788.
15. Oppenheimer SJ: Iron and its relation to immunity and infectious disease. J Nutr 2001, 131:S616-S635.
16. Patruta SI, Edlinger R, Sunder-Plassman G, Hörl WH: Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 1998, 9:655-663.
17. Marshall JC: Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2001, 29:S99-S106.
18. Bobbio-Pallavicini F, Verde G, Spriano P, Losi R, Bosatra MG, Iotti G, Chiranda M, Villa S: Body iron status in critically ill patients: significance of serum ferritin. Int Care Med 1989, 15:171-178.
19. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG: Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001, 16:36-41.
20. Hobisch-Hagen P, Wiedermann F, Mayr A, Fries D, Jelkmann W, Fuchs D, Hasibeder W, Mutz N, Klinger A, Schobersberger W: Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 2001, 29:743-747.
21. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC: Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care 2001, 29:473-478.
22. Elliot JM, Virankabutra T, Jones S, Tanudsintum S, Lipkin G, Todd S, Bion J: Erythropoietin mimics the acute phase response in critical illness. Crit Care 2003, 7:R35-R40.
23. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ: Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, doubled-blind, placebo-controlled trial. Crit Care Med 1999, 27:2346-2350.
24. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28:2773-2778.
25. Goodnough LT, Skikne B, Brugnara C: Erythropoietin, iron, and erythropoiesis. Blood 2000, 96:823-833.
26. Kaltwasser JP, Kessler U, Gottschalk R, Stucki G, Möller B: Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 2001, 28:2430-2436.
27. Gasché C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H: Intravenous iron and erythropoietin for anemia associated with Crohn disease. Ann Intern Med 1997, 126:782-787.
28. Fishbane S: Review of issues relating to iron and infection. Am J Kidney Dis 1999, 34:S47-S52.
29. Hoen B, Paul-Dauphin A, Hestin D, Kessler M: EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998, 9:869-876.
30. Hoen B, Paul-Dauphin A, Kessler M: Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients. Clin Nephrol 2002, 57: 57-461.
31. Brugnara C: Iron deficiency and erythropoiesis: new diagnosis approaches. Clin Chem 2003, 49:1573-1578.